TRACON Pharmaceuticals Profit Margin

TRACON Pharmaceuticals (TCON) currently reports a profit margin of 162.34% as of June 2024. That compares with -343.28% in the prior-year period — up 147.3% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore TRACON Pharmaceuticals's profit margin history and peer comparisons.

TRACON Pharmaceuticals's profit margin increased from -343.28% to 162.34% — a 147.3% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

TRACON Pharmaceuticals's profit margin of 162.34% is higher than the Healthcare sector average of 13.89%. That is roughly 1068.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but TRACON Pharmaceuticals's current 162.34% should be judged against Healthcare norms (sector average: 13.89%) and against TCON's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 162.34%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for TRACON Pharmaceuticals, and consider following TCON for alerts when major investors trade the stock.